European Centre for Disease Prevention and Control (ECDC)

Questions about the current Ebola outbreak in the Democratic Republic of the Congo and Uganda? We’ve published a 𝗤&𝗔 covering key facts about Ebola disease, including 𝘀𝘆𝗺𝗽𝘁𝗼𝗺𝘀, 𝘁𝗿𝗮𝗻𝘀𝗺𝗶𝘀𝘀𝗶𝗼𝗻, risks for 𝗽𝗲𝗼𝗽𝗹𝗲 𝗶𝗻 𝗘𝘂𝗿𝗼𝗽𝗲 and 𝘁𝗿𝗮𝘃𝗲𝗹𝗹𝗲𝗿𝘀 𝘁𝗼 𝗮𝗳𝗳𝗲𝗰𝘁𝗲𝗱 𝗮𝗿𝗲𝗮𝘀, and the ongoing 𝗽𝘂𝗯𝗹𝗶𝗰 𝗵𝗲𝗮𝗹𝘁𝗵 𝗿𝗲𝘀𝗽𝗼𝗻𝘀𝗲. The outbreak is caused by 𝗕𝘂𝗻𝗱𝗶𝗯𝘂𝗴𝘆𝗼 𝘃𝗶𝗿𝘂𝘀, for which there are currently no licensed vaccines or specific treatments available. While the situation continues to evolve, the overall risk for the general population in Europe is currently considered 𝗩𝗘𝗥𝗬 𝗟𝗢𝗪. Find all the information on the ECDC portal: ➡️ Ebola virus disease Q&A: https://bit.ly/ECDCEbolaQA ➡️ Factsheet on Ebola virus disease: https://lnkd.in/dvkhr62k ➡️ Outbreak page with latest information: https://lnkd.in/dp7FGEUc #Ebola #OutbreakResponse #PublicHealth #EbolaBundibugyo #QandA

In 2026, Eurosurveillance is celebrating its 30th anniversary with the theme ‘30 years of collaboration and strong #networks for #publichealth'. A good way of collaborating is to join up and co-author articles in our special #article category Euroroundups. These articles should look at a contemporary specific aspect or function of #communicabledisease surveillance, prevention or control in at least four European countries. You will find a more detailed description here https://lnkd.in/dTAn76iB If you plan to submit an article in this category from outside Europe, please contact the editorial office before submission.

Very excited to have collaborated as a "facilitator" in the second module of the "Summer School 2026: ToT course for trainers on prevention and control of multidrug-resistant microorganisms in health care settings" organized by European Centre for Disease Prevention and Control (ECDC). Great team!

Weekly respiratory viruses update - week 20. Respiratory virus activity remains low overall across the Europe: ➡️ RSV activity has returned to 𝗯𝗮𝘀𝗲𝗹𝗶𝗻𝗲 𝗶𝗻𝘁𝗲𝗿-𝘀𝗲𝗮𝘀𝗼𝗻𝗮𝗹 𝗹𝗲𝘃𝗲𝗹𝘀. ➡️ Influenza activity remains at 𝗯𝗮𝘀𝗲𝗹𝗶𝗻𝗲 𝗶𝗻𝘁𝗲𝗿-𝘀𝗲𝗮𝘀𝗼𝗻𝗮𝗹 𝗹𝗲𝘃𝗲𝗹𝘀. ➡️ SARS-CoV-2: activity remains at 𝗩𝗘𝗥𝗬 𝗟𝗢𝗪 levels overall. More info: https://erviss.org -------- 🚨 Remember! 🚨 Preventive measures can help reduce transmission and protect those at high risk. These include: 💪 vaccination 🙌 frequent handwashing ↔️ maintaining physical distance 👥 avoiding large gatherings 💨 proper ventilation 😷 wearing masks in healthcare settings. #ERVISS #RespiratoryViruses #COVID19 #ECDC

Check out the SMART toolkit, a new resource for communication on antibiotic resistance 👉🏽 https://smart.le.ac.uk/ The toolkit was developed based on social and behavioural research - and with input from our community at the ECDC Lighthouse! The ECDC Lighthouse is a community of practice promoting social and behavioural research for the prevention of infectious diseases. Check it out: https://lnkd.in/dNgCfuyV #SMARTMetaphors #SocialSciences #PublicHealth Learn more about the toolkit ⬇️

Cases of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Shigella infections are increasing in Europe, highlighting growing concerns around antimicrobial resistance (AMR). Since 2023, more than 2 300 infections linked to seven distinct resistant Shigella clusters have been reported in Europe and the United States, particularly among gay, bisexual and other men who have sex with men. 𝗦𝗮𝗳𝗲 𝘀𝗲𝘅 - 𝘀𝗮𝗳𝗲 𝘀𝘂𝗺𝗺𝗲𝗿 With the summer travel season, festivals and Pride events approaching, ECDC is encouraging awareness, early diagnosis and prevention efforts. Healthcare professionals are encouraged to consider sexually transmitted Shigella in patients presenting with gastrointestinal symptoms, carry out antimicrobial susceptibility testing when indicated, and support surveillance and genomic sequencing activities. 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀? 𝗔𝘀𝗸 𝘆𝗼𝘂𝗿 𝗱𝗼𝗰𝘁𝗼𝗿! Preventive measures such as avoiding sexual activity when experiencing diarrhoea or gastrointestinal symptoms, practising good hygiene, and seeking medical care for severe or persistent illness can help reduce transmission. Read more about the shigella situation in Europe: https://bit.ly/3RmBwEC #AMR #AntimicrobialResistance #Shigella #PublicHealth #SafeSex

Update on Ebola outbreak in the Democratic Republic of Congo - 21 May - ECDC publishes a risk assessment. --- The risk to the general population in Europe from the current Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda remains 𝗩𝗘𝗥𝗬 𝗟𝗢𝗪, according to our new risk assessment published today. At the same time, we are urging EU/EEA countries to strengthen preparedness as the situation continues to evolve. --- 𝗥𝗶𝘀𝗸 𝗮𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗰𝗼𝗻𝘁𝗿𝗼𝗹 𝗺𝗲𝗮𝘀𝘂𝗿𝗲𝘀 Exit screening in affected countries, as well as ensuring that travellers returning from affected areas are informed about symptoms and seek medical care promptly if symptoms develop are key for control of this outbreak. The likelihood of transmission within the EU/EEA is considered 𝗩𝗘𝗥𝗬 𝗟𝗢𝗪, as imported cases are expected to be rapidly identified and isolated, with infection prevention and control measures implemented immediately. 𝗘𝗖𝗗𝗖 𝘀𝘂𝗽𝗽𝗼𝗿𝘁𝗶𝗻𝗴 𝗽𝗿𝗲𝗽𝗮𝗿𝗲𝗱𝗻𝗲𝘀𝘀 𝗮𝗻𝗱 𝗿𝗲𝘀𝗽𝗼𝗻𝘀𝗲 We are monitoring the situation in full collaboration with international partners, including World Health Organization and Africa CDC. --- Read full news item ➡️ https://bit.ly/4v2xhwv Threat Assessment Brief ➡️ https://bit.ly/49b0kp9 Information on the outbreak ➡️ https://lnkd.in/dp7FGEUc Your questions about Ebola answered ➡️ https://bit.ly/ECDCEbolaQA #ECDC #PublicHealth #OutbreakResponse #EUHealthTaskForce #Bundibugyo

Ebola virus disease outbreak in the Democratic Republic of the Congo - ECDC update - 19 May 2026. A large outbreak of Bundibugyo ebolavirus disease is taking place in the Democratic Republic of the Congo (DRC). As of 19 May 2026, over 500 suspected cases and 130 deaths of Bundibugyo virus disease have been reported in the country and 30 cases have been laboratory-confirmed. Most cases to date have been reported in the Ituri Province and one case has been reported in Goma, North Kivu Province. --- 𝗔𝗹𝘁𝗵𝗼𝘂𝗴𝗵 𝗶𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗿𝗲𝗺𝗮𝗶𝗻𝘀 𝗹𝗶𝗺𝗶𝘁𝗲𝗱, 𝘄𝗲 𝗮𝘀𝘀𝗲𝘀𝘀 𝘁𝗵𝗲 𝗹𝗶𝗸𝗲𝗹𝗶𝗵𝗼𝗼𝗱 𝗼𝗳 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝗽𝗲𝗼𝗽𝗹𝗲 𝗹𝗶𝘃𝗶𝗻𝗴 𝗶𝗻 𝘁𝗵𝗲 𝗘𝗨/𝗘𝗘𝗔 𝘁𝗼 𝗯𝗲 𝗩𝗘𝗥𝗬 𝗟𝗢𝗪. --- 𝗦𝗶𝘁𝘂𝗮𝘁𝗶𝗼𝗻 𝗼𝘃𝗲𝗿𝘃𝗶𝗲𝘄 One American citizen has been exposed to the virus in a healthcare setting in DRC. According to the US' Centers for Disease Control and Prevention, this person and six high-risk contacts are being medically evacuated to a special isolation ward in Germany. In addition, Uganda has reported two imported cases in people who had travelled from DRC. 𝗖𝗼𝗺𝗽𝗹𝗲𝘅 𝘀𝗶𝘁𝘂𝗮𝘁𝗶𝗼𝗻 The outbreak is unfolding in a complex setting marked by insecurity and humanitarian challenges. Significant uncertainties remain regarding the scale of transmission, and the outbreak is likely larger than currently described. There are currently no licensed vaccines or specific treatments available for Bundibugyo virus disease. 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗨𝗻𝗶𝗼𝗻'𝘀 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 The European Union Reference Laboratory for Public Health on Emerging, Rodent-borne and Zoonotic Viral Pathogens (EURL-PH-ERZV) has provided recommendations on the diagnosis of Bundibugyo virus disease and biosafety considerations, as well as information on available diagnostic methods. The EURL is also offering diagnostic support, testing protocols, and advice on biorisk management to EU/EEA countries. 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗰𝗼𝗼𝗿𝗱𝗶𝗻𝗮𝘁𝗶𝗼𝗻 ECDC is actively liaising with key partners, including the Africa CDC, the European Commission, and World Health Organization to provide support through the EU Health Task Force in the response to this outbreak. ECDC is deploying an expert from the EU Health Task Force to Africa CDC’s headquarters to support coordination and operational planning. ECDC continues to monitor the situation closely and will update its assessment as new information becomes available. Find all information on the Ebola outbreak page ➡️ https://bit.ly/49WS6kC #Ebola #OutbreakResponse #EUHealthTaskForce

#TechnicalGuidance Key recommendations from ECDC’s rapid scientific advice on infection prevention and control (IPC) measures for patients with Andes virus (ANDV) disease in healthcare settings are now available in an editable and translatable infographic format. The infographic summarises recommendations on: • general IPC measures, • patient placement, • personal protective equipment (PPE), • occupational health measures, • cleaning and disinfection. Downloadable file here: https://bit.ly/496Zp9d Based on the rapid scientific advice: https://bit.ly/4wDu20e #PublicHealth #AndesHantavirus #RapidScientificAdvice #PreventionAndControl #ANDV

During the 79th World Health Assembly in Geneva, ECDC Director Dr Pamela Rendi-Wagner met with several international partners, reaffirming European Centre for Disease Prevention and Control (ECDC)’s commitment to global health security. ECDC Director met with Dr. Jean Kaseya - Director-General of Africa CDC, to discuss the Ebola disease outbreak in the Democratic Republic of the Congo, where they agreed to deploy an ECDC expert to Africa CDC in Addis Ababa. Meetings with Prof. Manaf Alqahtani, new CEO of Gulf Center For Disease Prevention and Control | المركز الخليجي للوقاية من الأمراض ومكافحتها, Prof Zoe Wainer - Director-General of The Australian Centre for Disease Control, and Prof. Vernon Lee - CEO, Communicable Diseases Agency (CDA) took place in the margins of the Assembly, reinforcing joint commitments to strengthening global health collaboration.    ECDC Director gave a presentation in the Side Event “Strengthening Global Pandemic Preparedness: Collaborative Approaches for Rapid and Resilient Responses”, hosted by CDA, Robert Koch Institute, and World Health Organization, highlighting the critical role of regional public health institutions in strengthening pandemic preparedness and response and referred to the joint effort in managing the hantavirus outbreak as a best practice example of strong collaboration.   ECDC remains committed to working closely with its international partners to address current and emerging global health challenges. #InternationalCooperation #ECDC #AfricaCDC #RKI #CDA #AustraliaCDC #WHO #GulfCDC